Trial intelligence / Profile preview

Mifepristone for cervical ripening and induction of labour at term

PACTR202605702730487Phase 3Not yet recruiting

Sponsor
Charles Efe Ogwah
Start
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in pregnancy and unfavorable cervix at term comparing Mifepristone arm with Placebo arm (2 arms). Primary endpoints: Mean Bishop score change, Participants with favourable cervix and 1 more. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

mifepristone
03

Conditions

pregnancyunfavorable cervix at term

Beyond the preview

Go deeper on PACTR202605702730487.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202605702730487.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call